VANGUARD GROUP INC - SIGILON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$279,878
+165.7%
300,9120.0%0.00%
Q4 2022$105,319
-30.7%
300,9120.0%0.00%
Q3 2022$152,000
-25.5%
300,912
+22.3%
0.00%
Q2 2022$204,000
-55.3%
246,142
-20.7%
0.00%
Q1 2022$456,000
-68.8%
310,502
-41.4%
0.00%
Q4 2021$1,461,000
-35.9%
529,559
+31.3%
0.00%
Q3 2021$2,278,000
-40.7%
403,183
+12.7%
0.00%
Q2 2021$3,839,000
-53.4%
357,807
-3.0%
0.00%
Q1 2021$8,241,000
+390.2%
368,737
+953.5%
0.00%
Q4 2020$1,681,00035,0000.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 10,370,369$28,622,0000.44%
HARBOURVEST PARTNERS LLC 740,740$2,044,0000.26%
SOUNDMARK WEALTH MANAGEMENT, LLC 25,555$71,0000.05%
Artal Group S.A. 276,000$762,0000.02%
Choate Investment Advisors 66,666$184,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$552,0000.01%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$4,099,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 142,781$394,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 509,629$1,407,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 234,153$646,0000.00%
View complete list of SIGILON THERAPEUTICS INC shareholders